A study group showed that c-Rel inhibition is a novel strategy to ameliorate GVHD reduced alloactivation without compromising T-cell mediated immune responses [31], and a small molecule c-Rel inhibitor had anti-proliferative effect in both GCB- and ABC-DLBCL cell lines [32]. This evidence concerns the gene REL and graft versus host disease.